Clinical Trial Update: A Study for Participants With Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This update summarizes results from a Phase 1/2 clinical trial for pancreatic cancer sponsored by Eli Lilly; results were posted on 2018-04-17.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Eli Lilly and Company | Conditions: Pancreatic Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-04-17